The European Commission has issued updated guidance to help drug manufacturers comply with new rules on fixing unique identifiers on the packs of almost all prescription medicines, as required under the EU Falsified Medicines Directive. The new rules will apply as of Feb. 9, 2019, although Belgium, Greece and Italy have the option of deferring their implementation application for up to six additional years.
The guidance, issued in the form of a revised question and answer document, contains new information on: some...